Neurocrine Biosciences, Inc. will participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit at 11:00 a.m. Eastern Time on Thursday, September 26, 2024. Chief Business ...
The ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol “ARQQ” and will begin trading on a split-adjusted basis on Wednesday, September 25, 2024. The new CUSIP for the ...
CrowdStrike today announced the winners of its annual Customer Excellence Awards and Global Partner Awards at Fal.Con 2024. Fal.Con 2024 welcomed a record 6,000 in-person attendees representing 2,300 ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Dyne Therapeutics Inc. 1.44% $3.42B ...
Quad/Graphics remains in a multi-year sideways consolidation pattern, with 2019 lows and 2022 highs acting as major ...
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help ...
Sanofi S.A. Part Cert 10.24% €8.18M ...
NAURA Technology Group Co. Ltd. A-1.72% ¥154.44B ...
Telefon AB L.M. Ericsson Series A 2.14% kr250.47B ...
Brunswick Corp. 6.5% Sr. Notes due 2048 0.25% ...